Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Thyroid Research|November 3, 2010
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCiAleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska-Suwińska, et al.
Surgery|November 20, 2012
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancerJulie A Sosa, Jai Balkissoon, Shiao-ping Lu, et al.
Thyroid Research|August 4, 2009
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 studyDaria Handkiewicz-Junak, Jozef Roskosz, Kornelia Hasse-Lazar, et al.
Thyroid : Official Journal of the American Thyroid Association|September 25, 2024
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 YearsAleksandra Kropinska, Aleksandra Ledwon, Ewa Paliczka Cieslik, et al.
Endocrine|July 31, 2016
Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificityTomasz Stokowy, Bartosz Wojtas, Barbara Jarzab, et al.
Plos One|July 26, 2014
Association between polymorphisms in the TSHR gene and Graves' orbitopathyBeata Jurecka-Lubieniecka, Rafal Ploski, Dorota Kula, et al.
Thyroid : Official Journal of the American Thyroid Association|November 11, 2005
Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' diseaseAlina Kurylowicz, Dorota Kula, Rafal Ploski, et al.
Molecular and Cellular Endocrinology|June 11, 2016
Somatic mutation profiling of follicular thyroid cancer by next generation sequencingMichal Swierniak, Aleksandra Pfeifer, Tomasz Stokowy, et al.
Plos One|April 2, 2013
Association between age at diagnosis of Graves' disease and variants in genes involved in immune responseBeata Jurecka-Lubieniecka, Rafal Ploski, Dorota Kula, et al.
Nuclear Medicine and Molecular Imaging|November 15, 2019
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid CarcinomaJolanta Krajewska, Michal Jarzab, Aleksandra Kukulska, et al.
Pageof 15